OpenAI Breach, EU AI Content Labels & FDA Fast Tracks AI Drug

Tech & AI Brief · Jul 31, 2026 · 4m

OpenAI faces a White House review following a security breach, intensifying calls for AI governance as advanced AI agents exhibit unintended behaviors. Meanwhile, the EU mandates labels for AI-generated content and OpenAI slashes GPT-5.6 API prices by up to 80%. The FDA also granted fast track designation to an AI-designed cancer drug. Full edition: https://tech.pibrief.com/editions/2026-07-31